Clinical and Translational Radiation Oncology

Papers
(The TQCC of Clinical and Translational Radiation Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
COVID-19: Global radiation oncology’s targeted response for pandemic preparedness144
4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience63
The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts62
Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac48
Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment47
A review of the role of MRI in diagnosis and treatment of early stage lung cancer36
The technical design and concept of a PET/CT linac for biology-guided radiotherapy35
Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac – Feasibility, workflow data and patient acceptance28
Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator27
Evaluation of deep learning-based multiparametric MRI oropharyngeal primary tumor auto-segmentation and investigation of input channel effects: Results from a prospective imaging registry23
Whole Brain Irradiation or Stereotactic RadioSurgery for five or more brain metastases (WHOBI-STER): A prospective comparative study of neurocognitive outcomes, level of autonomy in daily activities a21
Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer21
Radiomic biomarkers of tumor immune biology and immunotherapy response20
CDK 4/6 inhibitors combined with radiotherapy: A review of literature18
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience18
Dose-dependent volume loss in subcortical deep grey matter structures after cranial radiotherapy17
Ultrasound delta-radiomics during radiotherapy to predict recurrence in patients with head and neck squamous cell carcinoma17
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)16
Scalp angiosarcoma treated with linear accelerator-based boron neutron capture therapy: A report of two patients16
Incidence and dose-volume relationship of radiation pneumonitis after concurrent chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancer16
Long-term results of multimodal peptide receptor radionuclide therapy and fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma16
RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial15
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients15
Selection criteria for early breast cancer patients in the DBCG proton trial – The randomised phase III trial strategy14
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer14
Low dose anti-inflammatory radiotherapy for the treatment of pneumonia by covid-19: A proposal for a multi-centric prospective trial14
X-rays minibeam radiation therapy at a conventional irradiator: Pilot evaluation in F98-glioma bearing rats and dose calculations in a human phantom13
Auto-segmentations by convolutional neural network in cervical and anorectal cancer with clinical structure sets as the ground truth13
Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy13
Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center cli13
The changing role of radiation oncology professionals in a world of AI – Just jobs lost – Or a solution to the under-provision of radiotherapy?13
PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer12
Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer12
ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in locally recurrent rectal cancer12
European radiation oncology after one year of COVID-19 pandemic11
ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in primary locally advanced rectal cancer11
Blood-brain barrier permeability following conventional photon radiotherapy – A systematic review and meta-analysis of clinical and preclinical studies11
MR-guided stereotactic body radiation therapy for intracardiac and pericardial metastases11
GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer11
Conducting research in Radiation Oncology remotely during the COVID-19 pandemic: Coping with isolation11
Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer11
1.5 T MR-linac planning study to compare two different strategies of rectal boost irradiation11
Estimated clinical benefit of combining highly conformal target volumes with Volumetric-Modulated Arc Therapy (VMAT) versus conventional flank irradiation in pediatric renal tumors10
The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who do not receive definitive surgery of the tumor10
Decreased heart dose with deep inspiration breath hold for the treatment of gastric lymphoma with IMRT10
The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors10
[18F]-HX4 PET/CT hypoxia in patients with squamous cell carcinoma of the head and neck treated with chemoradiotherapy: Prognostic results from two prospective trials9
Recurrence of head and neck squamous cell carcinoma in relation to high-risk treatment volume9
Late toxicity in the brain after radiotherapy for sinonasal cancer: Neurocognitive functioning, MRI of the brain and quality of life9
Breast cancer radiation therapy: A bibliometric analysis of the scientific literature9
Analysis of the electron-stream effect in patients treated with partial breast irradiation using the 1.5 T MR-linear accelerator9
Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial9
Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac9
Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database9
ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic cancer9
A radiomics-based model for predicting local control of resected brain metastases receiving adjuvant SRS8
Hypoxia in relationship to tumor volume using hypoxia PET-imaging in head & neck cancer – A scoping review8
Prediction models for treatment-induced cardiac toxicity in patients with non-small-cell lung cancer: A systematic review and meta-analysis8
Machine learning highlights the deficiency of conventional dosimetric constraints for prevention of high-grade radiation esophagitis in non-small cell lung cancer treated with chemoradiation8
Concurrent paclitaxel and radiation therapy for the treatment of cutaneous angiosarcoma8
Replacing 30 Gy in 10 fractions with stereotactic body radiation therapy for bone metastases: A large multi-site single institution experience 2016–20188
High-dose rate brachytherapy in localized penile cancer: 5-Year clinical outcome analysis8
Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumab8
The role of large volume re-irradiation with Bevacizumab in chemorefractory high grade glioma8
Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer8
Efficacy and feasibility of re-irradiation using carbon ions for pancreatic cancer that recurs after carbon-ion radiotherapy8
Definition and validation of a radiomics signature for loco-regional tumour control in patients with locally advanced head and neck squamous cell carcinoma8
Cardiac radioablation in the treatment of ventricular tachycardia8
The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas7
A scoping review of small animal image-guided radiotherapy research: Advances, impact and future opportunities in translational radiobiology7
Prophylactic cranial irradiation in patients with small cell lung cancer in The Netherlands: A population-based study7
The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey7
In-vivo and in-vitro impact of high-dose rate radiotherapy using flattening-filter-free beams on the anti-tumor immune response7
Correlation of normal lung density changes with dose after stereotactic body radiotherapy (SBRT) for early stage lung cancer7
Auto-detection and segmentation of involved lymph nodes in HPV-associated oropharyngeal cancer using a convolutional deep learning neural network7
Lattice Radiation Therapy in clinical practice: A systematic review7
Immunotherapy with or without radiotherapy for metastatic or recurrent esophageal squamous cell carcinoma: A real-world study7
Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial7
Quality-of-life and toxicity in cancer patients treated with multiple courses of radiation therapy7
Prospective study of artificial intelligence-based decision support to improve head and neck radiotherapy plan quality7
Longitudinal characterization of the tumoral microbiome during radiotherapy in HPV-associated oropharynx cancer7
Combining radiotherapy and focused ultrasound for pain palliation of cancer induced bone pain; a stage I/IIa study according to the IDEAL framework7
A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence6
The individual risk of symptomatic radionecrosis after brain metastasis radiosurgery is predicted by a continuous function of the V12Gy6
The effect of pelvic radiation alone on lymphocyte subgroups6
High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes6
Dacomitinib and gedatolisib in combination with fractionated radiation in head and neck cancer6
Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre6
Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: Potential for improvement over time?6
The role of dietary supplements, including biotics, glutamine, polyunsaturated fatty acids and polyphenols, in reducing gastrointestinal side effects in patients undergoing pelvic radiotherapy: A syst6
De-intensification for HPV positive oropharyngeal cancer: and yet it moves!6
Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach6
Outcome and toxicity of hypofractionated image-guided SABR for spinal oligometastases6
Radiation dermatitis in patients treated with concurrent trastuzumab emtansine (T-DM1)6
PROMIS scores of patients undergoing neoadjuvant and adjuvant radiation therapy for surgically excised soft tissue sarcoma6
High-dose re-irradiation of intracranial lesions – Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose calculation6
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI6
Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial5
Long-term volumetric analysis of vestibular schwannomas following stereotactic radiotherapy: Practical implications for follow-up5
Voluntary versus ABC breath-hold in the context of VMAT for breast and locoregional lymph node radiotherapy including the internal mammary chain5
Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous Melanoma5
Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise5
Using the revised Edmonton symptom assessment scale during neoadjuvant radiotherapy for retroperitoneal sarcoma5
Impact of transitioning to an online course – A report from the ESTRO gyn teaching course5
Re-irradiation for oligoprogression under Nivolumab in recurrent head and neck squamous cell carcinoma: A case report5
Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation5
Nodal recurrence patterns on PET/CT after RTOG-based nodal radiotherapy for prostate cancer5
A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer5
Patient reported outcomes following proton pencil beam scanning vs. passive scatter/uniform scanning for localized prostate cancer: Secondary analysis of PCG 001-095
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis5
Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR) – A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gas5
Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study5
Clinical response assessment after contact X-Ray brachytherapy and chemoradiotherapy for organ preservation in rectal cancer T2-T3 M0: The time/dose factor influence5
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer5
Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review5
ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group5
Long-term patient-reported distress in locally advanced cervical cancer patients treated with definitive chemoradiation5
Dosimetric and volumetric outcomes of combining cyst puncture through an Ommaya reservoir with index-optimized hypofractionated stereotactic radiotherapy in the treatment of craniopharyngioma5
PD-L1 induction in tumor tissue after hypofractionated thoracic radiotherapy for non-small cell lung cancer5
Large anatomical changes in head-and-neck cancers – A dosimetric comparison of online and offline adaptive proton therapy5
Pseudo-siamese network combined with dosimetric and clinical factors, radiomics features, CT images and 3D dose distribution for the prediction of radiation pneumonitis: A feasibility study5
Morphological changes after cranial fractionated photon radiotherapy: Localized loss of white matter and grey matter volume with increasing dose5
Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis4
The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change?4
Adaptive radiotherapy for breast cancer4
Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal 4
Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre4
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894)4
Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged ≥ 60 years with Early-stage breast cancer (EPOPE): The rationale 4
Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer4
Proton therapy of a pregnant patient with nasopharyngeal carcinoma4
Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients4
Implementing cone-beam computed tomography-guided online adaptive radiotherapy in cervical cancer4
Evaluating single-institution resource costs of consolidative radiotherapy for oligometastatic non-small cell lung cancer using time-driven activity-based costing4
Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly4
Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study4
Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan4
Patient reported toxicity and quality of life after hypofractionated high-dose intensity-modulated radiotherapy for intermediate- and high risk prostate cancer4
Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer4
Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience4
Is prostate cancer radiotherapy using implantable rectum spacers safe and effective in inflammatory bowel disease patients?4
Prolonging deep inspiration breath-hold time to 3 min during radiotherapy, a simple solution4
Enhancing radiation response by a second-generation TRAIL receptor agonist using a new in vitro organoid model system4
A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic4
Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy4
Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of bevacizumab and corticosteroids4
Delineation uncertainties of tumour volumes on MRI of head and neck cancer patients4
0.053346872329712